Marco Boorsma

Title: Marco Boorsma: Innovator in Gene Expression Technology

Introduction

Marco Boorsma is a notable inventor based in Leeuwarden, Netherlands. He has made significant contributions to the field of biotechnology, particularly in gene expression systems. His work focuses on developing innovative solutions that enhance the regulation of gene expression in eukaryotic cells.

Latest Patents

Marco Boorsma holds a patent for an "Inducible alphaviral gene expression system." This invention provides novel expression vectors that allow for tight regulation of gene expression in eukaryotic cells. Specifically, the patent describes DNA vectors that comprise nucleotide sequences transcribed to form RNA molecules. These RNA molecules are replicated by a temperature-sensitive replicase, resulting in additional RNA molecules. The produced RNA can either be translated to produce a protein of interest or encode untranslated RNA molecules. The patent also outlines methods for producing heterologous proteins and untranslated RNA molecules, as well as methods for administering these molecules to individuals. Furthermore, pharmaceutical compositions containing the DNA and RNA molecules of the invention are provided, along with a pharmaceutically acceptable carrier.

Career Highlights

Marco Boorsma is associated with Cytos Biotechnology AG, where he continues to advance his research and development efforts. His work has been instrumental in pushing the boundaries of gene therapy and biotechnology.

Collaborations

Marco has collaborated with notable colleagues, including Wolfgang Andreas Renner and Lars Nieba. These collaborations have contributed to the success and impact of his research in the field.

Conclusion

Marco Boorsma's innovative work in gene expression technology exemplifies the potential of biotechnology to revolutionize medical treatments. His contributions continue to influence the field and pave the way for future advancements.